Aims and Scope

The Open Nanomedicine and Nanotechnology Journal is a peer-reviewed Open Access online journal, which aims to rapidly publish original, scientific research articles, full-length and mini-reviews, letter articles and guest edited single topic issues on the advances in the field of nanomedicine. The publication focus is on new advances in the medical applications of nanoscience and nanotechnology. The following categories of scientific papers are considered for publication after peer-review:

  • Communications and Short Notes -Preliminary results with significant importance.
  • Research Articles Full Papers - Detailed research data.
  • Reviews / Mini-reviews - A comprehensive survey.

The Open Nanomedicine and Nanotechnology Journal welcomes articles from the following research areas:

  • Nano-toxicology.
  • Nano-medical Sciences.
  • Nano-chemistry with biological applications.
  • Nano-devices for detection and/or treatment of diseases.
  • Nanoparticles based design and development of new modalities for detection, imaging and therapy of cancer and other diseases.
  • Nano-materials
  • Nano-particles
  • Nano-structures
  • Nano- drug delivery
  • Nanofabrication
  • Spectroscopy
  • Biological systems
  • Nano-electronics and Nano-optics
  • Nano-electronics, molecular electronics, Nanoscale physics
  • Nanocomposites and nano-porous materials
  • Nano-bioscience and nano-biosensors
  • Nano-mechanics
  • Nano-devices
  • Nano-biotechnology
  • Computational nanotechnology, Synthesis and processing
  • Molecular machines, motors, and molecular self-assembly
  • Nano-fluidics
  • Nano-metrology and instrumentation

The Open Nanomedicine and Nanotechnology Journal is of interest to researchers from both academic and industry.

Editor's Choice

Biofabricated Silver Nanoparticles Synergistically Activate Amphotericin B Against Mature Biofilm Forms of Candida Albicans

Shivkrupa D. Halbandge, Supriya P. Mortale, Sankunny Mohan Karuppayil


Biofilm formation by Candida albicans is a significant clinical challenge. Fungal biofilms are resistant to most of the currently available antifungal agents. Amphotericin-B (AmB) is an antifungal agent used for the treatment of systematic fungal infections but it is well known for its toxicities and side-effects. Novel approaches are needed to treat these infections that can reduce its toxicities.


Current study aims to evaluate the efficacy of silver nanoparticles (SNPs) alone and in combination with AmB against growth and biofilm formation in C. albicans.


Combinations of SNP-AmB were tested against planktonic growth and biofilm formation in vitro. Micro broth dilution method was used to study planktonic growth and biofilm formation. The fractional inhibitory concentration indices (FICI) were calculated by using a checkerboard format. Biofilm formation was analyzed by using XTT-metabolic assay.


MIC of AmB for developing biofilm was lowered by 16 fold in combination with SNPs. The calculated fractional inhibitory concentration indices were 0.1875 suggesting that this interaction is synergistic. Similarly, the mature biofilms were significantly prevented by SNPs-AmB combination. This interaction was synergistic. Furthermore, interaction between SNPs and AmB against planktonic growth was additive. Hemolytic activity assay was carried out on these drugs and combinations. Drug required for inhibition alone as well as in combination did not exhibit hemolytic activity.


The combinations with SNPs lead to decreases in the dosage of AmB required for anti-Candida activity. SNPs-AmB combination could be an effective strategy against biofilm formed by C. albicans.

September 30, 2017

Quick Links

Indexing Agencies